MyndTec, Inc. AI Stock Analysis
Want to see TSE:MYTC full AI Analyst Report?
MyndTec, Inc. (MYTC) AI Stock Analysis
MyndTec, Inc.
(CNQX:MYTC)
The score is driven primarily by very weak financial performance (shrinking revenue, persistent losses, negative equity, and negative free cash flow). Technicals also weigh heavily as the stock is in a pronounced downtrend (below major moving averages with negative MACD and very low RSI). Valuation impact is limited because P/E and dividend yield are not available.
MyndTec, Inc. (MYTC) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 159.38K
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- -8.49
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Canada
- Employees
- 7
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
MyndTec, Inc. Business Overview & Revenue Model
Company Description
MyndTec Inc. is a medical technology firm dedicated to the research, development, and distribution of therapeutic solutions. Its primary focus is on individuals in Canada and the United States who experience paralysis resulting from stroke or spinal...
How the Company Makes Money
MyndTec makes money primarily through the sale and distribution of its flagship product, MyndMove, to healthcare providers, rehabilitation centers, and hospitals. The company generates revenue by offering MyndMove as a service, where customers pay fo...
MyndTec, Inc. Financial Statement Overview
Summary
Financial statements indicate severe weakness: revenue is shrinking sharply (~40% YoY TTM), operating and net margins are deeply negative, equity is negative across periods, and operating/free cash flow remain negative despite some improvement in gross margin and reduced burn.
Income Statement
18Very NegativeBalance Sheet
14Very NegativeCash Flow
16Very Negative| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.67K | 111.43K | 137.31K | 255.80K | 605.57K | 162.63K |
| Gross Profit | 50.95K | 4,856 | 54.90K | 67.44K | 354.62K | 67.04K |
| EBITDA | -1.02M | -1.13M | -1.58M | -1.88M | -2.62M | -1.15M |
| Net Income | -1.09M | -1.25M | -1.72M | -2.25M | -3.34M | -1.81M |
Balance Sheet | ||||||
| Total Assets | 182.68K | 313.57K | 554.85K | 642.57K | 3.82M | 1.65M |
| Cash, Cash Equivalents and Short-Term Investments | 90.21K | 117.48K | 187.41K | 68.62K | 377.06K | 668.58K |
| Total Debt | 429.65K | 463.14K | 455.51K | 734.19K | 2.08M | 1.71M |
| Total Liabilities | 1.45M | 1.55M | 1.47M | 1.57M | 7.37M | 3.48M |
| Stockholders Equity | -1.27M | -1.24M | -919.78K | -925.34K | -3.54M | -1.83M |
Cash Flow | ||||||
| Free Cash Flow | -960.86K | -940.81K | -976.91K | -2.39M | -1.50M | -1.41M |
| Operating Cash Flow | -960.86K | -919.80K | -976.91K | -2.34M | -1.44M | -1.40M |
| Investing Cash Flow | 0 | -21.00K | 0 | -42.01K | -64.44K | -19.40K |
| Financing Cash Flow | 964.80K | 870.87K | 1.10M | 2.08M | 1.21M | 1.67M |
MyndTec, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MYTC, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, equal to the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 21.57 is Positive, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MYTC.
MyndTec, Inc. Peers Comparison
Overall Rating
TSE:PRN58Neutral
TSE:PINK44Neutral
TSE:TLT41.2Neutral
TSE:ASTI40Underperform- TSE:MYTC40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TSE:PRN | 58Neutral | CAD 398.50M | -8.53 | -59.18% | ― | 64.70% | 30.61% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:PINK | 44Neutral | CAD 23.78M | -1.11 | -303.05% | ― | 35.27% | 58.34% |
| TSE:TLT | 41Neutral | CAD 55.89M | -13.03 | -130.04% | ― | -24.86% | 18.29% |
| TSE:ASTI | 40Underperform | CAD 275.99K | -0.18 | 23.95% | ― | 8.66% | -545.88% |
| TSE:MYTC | 40Underperform | CAD 146.74K | -0.25 | 41.81% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:MYTC | MyndTec, Inc. | 0.01 | -0.01 | -50.00% | |
| TSE:PINK | Perimeter Medical Imaging Ai Inc | 0.14 | -0.05 | -23.68% | |
| TSE:PRN | Profound Medical | 11.18 | 1.76 | 18.68% | |
| TSE:TLT | Theralase Technologies | 0.18 | -0.02 | -11.90% | |
| TSE:ASTI | Aquarius Surgical Technologies | 0.01 | 0.00 | 0.00% |
MyndTec, Inc. Corporate Events
MyndTec Raises Over $1.06 Million as It Closes Tenth Tranche of Private Placement
PositiveMyndTec Inc. has completed a tenth tranche of its non-brokered private placement, issuing 618,118 units at $0.20 per unit for gross proceeds of $123,623.60, bringing total funds raised under the offering to $1,067,493.40 through 5,337,323 units. Each...
MyndTec Completes Ninth Tranche of Private Placement
NeutralMyndTec Inc. has completed the ninth tranche of its non-brokered private placement, raising $110,785.20 through the issuance of 553,926 units, each comprising one common share and a half-share purchase warrant. The proceeds will be used for general c...
MyndTec Inc. Corrects Private Placement Figures in Recent Press Release
NeutralMyndTec Inc. announced a correction to its previous press release regarding the eighth tranche of its non-brokered private placement, adjusting the number of units issued and the aggregate gross proceeds. The correction does not affect other details...
MyndTec Inc. Announces Board Resignation of P. Harvey Griggs
NegativeMyndTec Inc. announced the resignation of P. Harvey Griggs from its Board of Directors, effective November 26, 2025, due to personal health reasons. Dr. Griggs, an early investor and six-year director, was praised for his contributions to the company...
MyndTec Completes Seventh Tranche of Private Placement, Strengthening Financial Position
PositiveMyndTec Inc. has successfully completed the seventh tranche of its non-brokered private placement, raising $52,451.25 through the issuance of 262,027 Units at $0.20 per Unit. This brings the total proceeds from the offering to $762,529.60. The funds...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jan 27, 2026